RxDoctor Payments Data

Lesley Anne Kellie

Internal Medicine · Louisville, KYNPI 1861768962

Payments from drug & device makers

$1,056in general payments, 2019–2025

Across 52 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$331
  • Boehringer Ingelheim$231
  • Amgen$143
  • Insmed, Inc.$125
  • Astellas Pharma US Inc$106
  • Sanofi-aventis U.S. LLC$27
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$79876%
  • Education$25824%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,056 in reported general payments places this provider in the 65th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$198,407
Medicare patients
338
Services billed
2,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin67$86,114
EliquisApixaban50$55,232
OzempicSemaglutide45$44,922
MounjaroTirzepatide37$40,438
XareltoRivaroxaban27$34,614
TrulicityDulaglutide22$27,719
Repatha SureclickEvolocumab23$24,420
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$24,153
LinzessLinaclotide15$9,992
Janumet XrSitagliptin Phos/Metformin Hcl14$9,107
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$6,567
Atorvastatin Calcium670$5,962
SymbicortBudesonide/Formoterol Fumarate12$4,652
Levothyroxine Sodium408$4,550
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$4,111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$231$92,68179 claims
Novo NordiskOzempic$331$44,92245 claims
MerckJanumet Xr$11$9,10714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →